Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials-Reference-Cited by-同舟云学术

Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials

Published:2017-07-14 Issue: Volume:7 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Eissa Ibrahim Ragab,Naoe Yoshinori,Bustos-Villalobos Itzel,Ichinose Toru,Tanaka Maki,Zhiwen Wu,Mukoyama Nobuaki,Morimoto Taishi,Miyajima Noriyuki,Hitoki Hasegawa,Sumigama Seiji,Aleksic Branko,Kodera Yasuhiro,Kasuya Hideki

Funder

Japan Society for the Promotion of Science

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference87 articles.

1. New viruses for cancer therapy: meeting clinical needs;Miest;Nat Rev Microbiol,2014

2. Herpes simplex viruses;Whitley;Clin Infect Dis,1998

3. Experimental therapy of human glioma by means of a genetically engineered virus mutant;Martuza;Science,1991

4. Talimogene laherparepvec: first global approval;Greig;Drugs,2016

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Tanapoxvirus Variants Expressing mIL-2 and mCCL-2 Regress Human Pancreatic Cancer Xenografts in Nude Mice;Biomedicines;2024-08-12

2. Safety of non-replicative and oncolytic replication-selective HSV vectors;Trends in Molecular Medicine;2024-08

3. Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment;Molecular Therapy - Oncolytics;2023-12

4. Immunotherapeutic Agents for Intratumoral Immunotherapy;Vaccines;2023-11-14

5. Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy;Microorganisms;2023-10-29